Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma

Masaud Shah, Sung Ung Moon, Ji-Hye Choi, Min Jae Kim, Hyun Goo Woo · 2025

Read Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma by Masaud Shah, Sung Ung Moon, Ji-Hye Choi, Min Jae Kim, Hyun Goo Woo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12720462.txt.

Description

Shah and co-authors target a fusion gene that drives liver cancer growth. Gene fusions are known cancer drivers, but liver cancer fusions are less mapped. RNA data from 68 liver cancer patients flagged one fusion. The fusion joins SLC39A14 to PIWIL2. Its promoter drives excess output of a cut form of PIWIL2.

The cut protein keeps its MID and PIWI parts and binds two cancer partners. Model tests showed those binds fuel tumor activity. The team built decoy peptides to block the binds. One peptide, NEP1, curbed tumor activity in four cell lines. Paired with a standard drug, it also cut drug resistance.

Catalog record

CREATORMasaud Shah, Sung Ung Moon, Ji-Hye Choi, Min Jae Kim, Hyun Goo Woo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12720462

Browse the full library · About the Tower of Babel